Opinion

Sarah Clark: James P. Allison and Tasuku Honjo’s work revolutionized cancer treatment

Sarah Clark/LinkedIn

Feb 28, 2025, 13:34

Sarah Clark: James P. Allison and Tasuku Honjo’s work revolutionized cancer treatment

Sarah Clark, Business Development Manager, shared a post on X:

“James P. Allison and Tasuku Honjo’s work revolutionized cancer treatment – turning immunotherapy from a concept into a lifesaving reality. Their breakthroughs in checkpoint blockade therapy continue to shape the future of oncology.”

cancer James P. Allison OncoDaily Oncology Sarah Clark Tasuku Honjo

Aparna Parikh Has Been Named Program Director for the GI Medical Oncology Program at Mass General Brigham

Herbert Loong: Grateful for the Journey with ASCO International Affairs Committee

Unreleased Decision Letters From 2024–2025 Now Available - FDA

Servier and IDEAYA Biosciences Partner to Advance Darovasertib for Uveal Melanoma

FDA Grants Breakthrough Therapy Designation to Zongertinib (HERNEXEOS) for First-Line Treatment of HER2-Mutant Advanced NSCLC

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Voices

Sep 6, 2025, 20:00

Brunilda Haxhiu: Uniting for Better Breast Cancer Care in the Balkans

Voices

Sep 6, 2025, 19:13

Ola Khorshid: Ontic Best of Lung Cancer Congress

OncoDaily Pulse

Sep 6, 2025, 19:01

Jianhua Zhang: Meet the Experts of VIRO 2025

Blog Posts

Sep 6, 2025, 18:53

Florian Lordick: Two European Top Oncologists at Masaryk Memorial Cancer Institute

Blog Posts

Sep 6, 2025, 18:06

Omnia Korani Highlights Friendship and Connections at 1st ESO College Convention

OncoDaily Pulse

Sep 6, 2025, 18:05

Tian Zhang: Meet the Experts of VIRO 2025

Societies

Sep 6, 2025, 17:59

Approaching Deadline for ICRS - Asia Pacific Clinical Research Opportunity - ASCO

Voices

Sep 6, 2025, 17:52

Amrit Kaur Kaler: Case of Complete Response in SDH positive Paragangliomas

Voices

Sep 6, 2025, 17:48

Rob Winn: Driving Forward Research, Strengthening Care, Building Community

Science

Sep 6, 2025, 17:39

MD Anderson Cancer Center's Research Highlights

Insight

Sep 6, 2025, 17:28

Highlights From 2025 IASLC World Conference on Lung Cancer

Science

Sep 6, 2025, 16:14

Stephen Schoenberger: Remarkable Study on the Ontogeny of Neoantigen-Specific CD4+ T Cell Responses